Back

Prevalence and predictors of pulmonary vascular disease in patients with advanced heart failure with reduced ejection fraction

22 May 2023 (13:34 - 14:42)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 3 Pulmonary Hypertension HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Samuel Vysocansky

The National Institute of Cardiovascular Diseases, Bratislava (Slovakia)

5 More presentations in this session

Presentation thumbnail
Estimating prognosis in connective tissue disease related pulmonary hypertension - the value of pulmonary artery compliance
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Pulmonary hypertension classification based on machine learning using standart chest X-ray:ATA artificial intelligence study-1
Associate Professor T. Kivrak (Elazig, TR)
Abstract Slides
Presentation thumbnail
The particularities of cardiopulmonary exercise testing in patients with pulmonary hypertension and heart failure in the early period after myocardial revascularization.
Mrs J. Cazacu (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Four-strata risk-assessment tool for pulmonary hypertension: can we associate it with hemodynamic parameters?
Doctor B. Silva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
CTEPH: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on diagnosis accuracy by right heart catheterization.
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in valvular and pulmonary 3

The Event

Event poster

Heart Failure 2023

22 May 2023 13:34 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources